“Corporate Investment Strategies – Assessing Risk & Seizing Growth Opportunities”
How does a corporation set-up a successful enterprise risk management system? What investment strategies should business leaders pursue to seize growth opportunities while managing risk? And what role does a board play in making these decisions? Join Pfizer’s Executive Vice President, Chief Compliance & Risk Officer Douglas Lankler, JD ’90 and Cornell Trustee Member and Managing Partner & Chief Investment Officer at Mansa Capital Ruben King-Shaw, BS ’83 as they share what it takes to set up a successful and ethical corporate compliance program and insights into what ethical factors they consider before making strategic investments. Our program moderator is Jason E. Macias, BS ’00, Corporate Counsel, Pfizer Inc.
Friday, September 13, 2013
8 - 8:30 AM – Registration and Continental Breakfast
8:30 – 9:30 AM – Presentation
9:30 – 10 AM – Q&A (Ethics CLE credit pending approval)
Cornell Club NYC
6 East 44th Street
Ivy Room (4th Floor)
$20.00 per person
CLE credit is free of charge and is appropriate for both transitional and non-transitional NY CLE credit.
Attendees may be eligible to receive 1.5 hours of New York credit in the area of Ethics
Please register online or by calling the Alumni Affairs Office at 607.255.5251 by Friday, September 6th.